Oshi Health Survey Highlights Overlooked Link Between Women’s Hormonal and GI Conditions

New updates have been reported about Oshi Health.

Oshi Health is spotlighting a substantial care gap for women with digestive disorders, releasing survey data during Women’s Health Month that underscores how hormonal and reproductive conditions intersect with GI disease and access barriers. In a poll of female patients ages 35 to 55, 52% reported at least one hormonal or reproductive condition alongside their GI issues, and 67% had already seen a gastroenterologist without sustained symptom relief before turning to Oshi’s virtual, multidisciplinary model.

The findings support emerging research on bidirectional gut–endocrine interactions and help clarify why women, who experience irritable bowel syndrome at nearly double the rate of men, often fail to improve under traditional, siloed GI care. Among respondents with comorbid conditions, perimenopause or menopause was most common at 26%, followed by pelvic floor dysfunction at 11%, PCOS at 7%, and endometriosis at 6%, suggesting broad applicability for integrated GI, hormonal, and pelvic floor management.

The survey also exposes systemic access challenges that create demand for Oshi’s virtual platform: limited availability of coordinated GI, nutrition, and behavioral health services pushes many women to self-manage. Before joining Oshi, 73% of respondents had already changed their diet and an equal share had tried supplements or over-the-counter remedies, while 51% had used prescription drugs, reflecting both unmet need and spend in fragmented care pathways.

Oshi Health’s model assigns each patient a care team that includes a GI clinician, registered dietitian, and gut–brain specialist working in coordination and designed to augment existing primary and specialty relationships rather than replace them. Access, cost, and integration were core adoption drivers, with 94% of surveyed patients rating quick appointment availability as important, 92% citing cost and insurance coverage, and 88% prioritizing whole-person, coordinated care when choosing Oshi.

Reported satisfaction and outcomes indicators are strong, underscoring potential value for payers and employers seeking lower total cost of care and reduced productivity loss from GI disease. Ninety-seven percent of respondents rated their GI clinician as helpful or very helpful, 90% said the same of their dietitian, and 85% found their gut–brain specialist helpful, while 86% feel more in control of symptoms, 84% are better able to work and manage daily responsibilities, and 74% can participate in social activities without constant GI concern.

For Oshi Health, the survey both validates its whole-person GI strategy and provides data to support further expansion with health plans, self-insured employers, health systems, and GI practices. The company has also published peer-reviewed outcomes covering more than 11,000 patients in the Journal of Medical Internet Research, strengthening its evidence base as demand grows for scalable, virtual GI solutions that integrate hormonal, behavioral, and nutritional factors into routine care for women.